(5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one - Names and Identifiers
Name | (5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one
|
Synonyms | Noroxymorphinone NOROXYMORPHINONE Einecs 282-186-5 7,8-Didehydro-4,5α-epoxy-3,14-dihydroxymorphinan-6-one (5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one Morphinan-6-one, 7,8-didehydro-4,5-epoxy-3,14-dihydroxy-, (5α)-
|
CAS | 84116-46-1
|
EINECS | 2821865 |
(5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one - Physico-chemical Properties
Molecular Formula | C16H15NO4
|
Molar Mass | 285.3 |
Density | 1.59±0.1 g/cm3(Predicted) |
Melting Point | >230 °C (decomp) |
Boling Point | 555.9±50.0 °C(Predicted) |
pKa | 9.11±0.40(Predicted) |
(5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one - Upstream Downstream Industry
(5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one - Introduction
(5alpha)-7,8-didehydro-4,5-epoxy-3, also known as (5alpha)-7,8-didehydro-4,5-epoxy-3, is an organic compound. Its molecular formula is C17H17NO4 and its molecular weight is 311.32.
Regarding the properties of this compound, it is a white crystalline solid that can be dissolved in a solvent. Its melting point is in the range of 203-204 degrees Celsius, and it is also a very stable compound.
One of the main uses of this compound is in the field of medicine, where it is a precursor of narcotic drugs. It can be synthesized through a series of chemical reactions and used to prepare other related anesthetic drugs. In addition, in some studies, it may also be used as a compound of the alkaloid family for drug development and research.
The method of preparing this compound is mainly synthesized by organic synthetic chemical methods. The specific synthetic route may vary depending on the purpose and conditions of the study, but generally includes a series of chemical reactions such as esterification, reduction, cyclization, etc.
Regarding safety information, this is a chemical and should be handled in accordance with relevant safety practices. It may cause irritation to the eyes, skin and respiratory tract, so appropriate personal protective measures should be taken during operation. During handling and storage, care should be taken to prevent contact with oxidants and combustibles. Refer to the detailed safety data sheet of the compound for specific safety measures.
Last Update:2024-04-09 21:54:55